Myles Minter
Stock Analyst at William Blair
(3.27)
# 438
Out of 5,218 analysts
22
Total ratings
66.67%
Success rate
2301.50%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Camp4 Therapeutics | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Nov 5, 2024 | |
argenx | Upgrades: Outperform | n/a | n/a | n/a | 2 | Nov 1, 2024 | |
Korro Bio | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Aug 14, 2024 | |
Reneo Pharmaceutical... | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Nov 15, 2023 | |
Neumora Therapeutics | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 71 | 17.2 | 312.79% | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | n/a | n/a | n/a | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 116 | 126.68 | -8.43% | 1 | Feb 24, 2020 |